Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
McGuire FP, Martinez R, Lenz A, et al. Current Reviews in Musculoskeletal Medicine 2025;18:611-619.
What it found
Summarises the proposed pathways (VEGFR2, nitric oxide, ERK1/2, inflammation), counts three small human reports, and concludes that BPC-157 should be treated as investigational.
Limitations
Narrative review, not systematic.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.